BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 188629)

  • 1. On the role of the central noradrenergic and dopaminergic systems in the regulation of TSH secretion in the rat.
    Krulich L; Giachetti A; Marchlewska-Koj A; Hefco E; Jameson HE
    Endocrinology; 1977 Feb; 100(2):496-505. PubMed ID: 188629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenergic and dopaminergic modulation of thyrotropin secretion in the rat.
    Jaffer A; Russell VA; Taljaard JJ
    Brain Res; 1987 Feb; 404(1-2):267-72. PubMed ID: 3105810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies on the noradrenergic control of luteinizing hormone secretion in the domestic fowl.
    Buonomo FC; Scanes CG
    Gen Comp Endocrinol; 1983 Mar; 49(3):358-63. PubMed ID: 6132854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual action of adrenergic system on the regulation of thyrotrophin secretion in the male rat.
    Männistö ; Ranta T; Tuomisto J
    Acta Endocrinol (Copenh); 1979 Feb; 90(2):249-58. PubMed ID: 105532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin-releasing hormone in the pancreas and brain of the rat is regulated by central noradrenergic and dopaminergic pathways.
    Engler D; Chad D; Jackson IM
    J Clin Invest; 1982 Jun; 69(6):1310-20. PubMed ID: 6806317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of central noradrenergic neurons in the control of thyrotropin secretion in the rat.
    Annunziato L; Di Renzo G; Lombardi G; Scopacasa F; Schettini G; Preziosi P; Scapagnini U
    Endocrinology; 1977 Mar; 100(3):738-44. PubMed ID: 401025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice.
    Dolphin AC; Jenner P; Marsden CD
    Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noradrenergic and dopaminergic interactions in escape behavior: analysis of uncontrollable stress effects.
    Anisman H; Ritch M; Sklar LS
    Psychopharmacology (Berl); 1981; 74(3):263-8. PubMed ID: 6791235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
    Dadkar VN; Dahanukar SA; Sheth UK
    Indian J Med Res; 1979 Sep; 70():492-4. PubMed ID: 535961
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for alpha 1-adrenergic stimulatory control of in vitro release of immunoreactive thyrotropin-releasing hormone from rat median eminence: in vivo corroboration.
    Tapia-Arancibia L; Arancibia S; Astier H
    Endocrinology; 1985 Jun; 116(6):2314-9. PubMed ID: 2986944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotransmitter control of thyrotropin secretion in the rat.
    Tuomisto J; Ranta T; Männistö P; Saarinen A; Leppälioto J
    Eur J Pharmacol; 1975 Feb; 30(2):221-9. PubMed ID: 236190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catecholamine synthesis inhibitors acutely modulate [3H]estradiol binding by specific brain areas and pituitary in ovariectomized rats.
    Thompson MA; Woolley DE; Gietzen DW; Conway S
    Endocrinology; 1983 Sep; 113(3):855-65. PubMed ID: 6135604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-phenylethylamine and locomotor activity in mice. Interaction with catecholaminergic neurones and receptors.
    Jackson DM
    Arzneimittelforschung; 1975 Apr; 25(4):622-6. PubMed ID: 168908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for dopaminergic control of thyrotrophin secretion in the rat.
    Ranta T; Männistö P; Tuomisto J
    J Endocrinol; 1977 Mar; 72(3):329-35. PubMed ID: 404378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine and L-dopa: inhibition of thyrotropin-stimulated thyroidal thyroxine release.
    Maayan ML; Sellitto RV; Volpert EM
    Endocrinology; 1986 Feb; 118(2):632-6. PubMed ID: 2867890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of dopamine on the in vitro release of gonadotropin-releasing hormone.
    Jarjour LT; Handelsman DJ; Raum WJ; Swerdloff RS
    Endocrinology; 1986 Oct; 119(4):1726-32. PubMed ID: 3019641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotransmitter control of thyrotropin secretion.
    Krulich L
    Neuroendocrinology; 1982; 35(2):139-47. PubMed ID: 6127638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the hypothalamic paraventricular nucleus in the secretion of thyrotropin under adrenergic and cold-stimulated conditions in the rat.
    Ishikawa K; Kakegawa T; Suzuki M
    Endocrinology; 1984 Feb; 114(2):352-8. PubMed ID: 6418529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative ontogeny of opioid and catecholaminergic regulation of thyrotropin secretion in the rat.
    Ignar DM; Kuhn CM
    Endocrinology; 1988 Jul; 123(1):567-71. PubMed ID: 3133201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotransmitter effects on in vitro prolactin and growth hormone release from fowl pituitary glands: dopamine and noradrenaline.
    Hall TR; Harvey S; Chadwick A
    Gen Pharmacol; 1984; 15(4):321-5. PubMed ID: 6149167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.